Morus alba Linne A pharmaceutical composition comrprising Morus alba Linne extract for preventing or treating benign prostatic hyperplasia

摘要

The present invention relates to a composition for preventing or treating prostatic hyperplasia, comprising an extract of Morus alba Linne and an extract of Curcuma zedoaria. Specifically, the present invention relates to a pharmaceutical composition, a food composition, and a quasi-drug composition for preventing or treating prostatic hyperplasia, all of which comprise an extract of Morus alba Linne or a fraction thereof, and an extract of Curcuma zedoaria or a fraction thereof as effective components; and to a method of preventing or treating prostatic hyperplasia by using the pharmaceutical composition. The compositions of the present invention, comprising the extract of Morus alba Linne, the extract of Curcuma zedoaria, or a mixture of the extract of Morus alba Linne and the extract of Curcuma zedoaria as an effective component show comparable or superior effects in the prevention, alleviation, and treatment of prostatic hyperplasia, compared to the effects of Finasteride, which is currently used as a medication for prostatic hyperplasia. Additionally, the compositions of the present invention are derived from natural substances, and thus can be safely used without side effects in the prevention, treatment, and alleviation of prostatic hyperplasia.